Maxcyte (MXCT) Other Working Capital Changes (2020 - 2026)

Maxcyte (MXCT) has reported Other Working Capital Changes for 7 consecutive years, with -$679000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Working Capital Changes rose 54.88% year-over-year to -$679000.0 in Q2 2026; TTM through Jun 2026 was $18000.0, a 100.98% increase from a year earlier, with the FY2025 full-year figure at -$1.7 million, down 136.67% from the prior year.
• Other Working Capital Changes was -$679000.0 for Q2 2026 at Maxcyte, down from -$456000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $2.2 million in Q3 2021 and troughed at -$1.1 million in Q1 2022.
• A 3-year average of $200400.0 and a median of -$17700.0 in 2021 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 518.18% in 2022, down 388.91% in 2022.
• Over 5 years, Other Working Capital Changes stood at -$3.9 million in 2022, then surged by 86.61% to -$517000.0 in 2023, then sank by 343.52% to -$2.3 million in 2024, then soared by 67.77% to -$739000.0 in 2025, then advanced by 8.12% to -$679000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$679000.0 (Q2 2026), -$456000.0 (Q1 2026), and -$739000.0 (Q4 2025), per Business Quant data.